140 related articles for article (PubMed ID: 29872627)
1. Enhanced glioma-targeting and stability of
Zhang M; Lu W
Acta Pharm Sin B; 2018 Jan; 8(1):106-115. PubMed ID: 29872627
[TBL] [Abstract][Full Text] [Related]
2. Glioma-Targeted Drug Delivery Enabled by a Multifunctional Peptide.
Zhang M; Chen X; Ying M; Gao J; Zhan C; Lu W
Bioconjug Chem; 2017 Mar; 28(3):775-781. PubMed ID: 27966896
[TBL] [Abstract][Full Text] [Related]
3. A stabilized peptide ligand for multifunctional glioma targeted drug delivery.
Ying M; Shen Q; Zhan C; Wei X; Gao J; Xie C; Yao B; Lu W
J Control Release; 2016 Dec; 243():86-98. PubMed ID: 27693752
[TBL] [Abstract][Full Text] [Related]
4. Stabilized Heptapeptide A7R for Enhanced Multifunctional Liposome-Based Tumor-Targeted Drug Delivery.
Ying M; Shen Q; Liu Y; Yan Z; Wei X; Zhan C; Gao J; Xie C; Yao B; Lu W
ACS Appl Mater Interfaces; 2016 Jun; 8(21):13232-41. PubMed ID: 27195531
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Glioblastoma Targeting Ability of Carfilzomib Enabled by a
Zhang M; Lu L; Ying M; Ruan H; Wang X; Wang H; Chai Z; Wang S; Zhan C; Pan J; Lu W
Mol Pharm; 2018 Jun; 15(6):2437-2447. PubMed ID: 29734808
[TBL] [Abstract][Full Text] [Related]
6. Liposome-Based Systemic Glioma-Targeted Drug Delivery Enabled by All-d Peptides.
Ying M; Zhan C; Wang S; Yao B; Hu X; Song X; Zhang M; Wei X; Xiong Y; Lu W
ACS Appl Mater Interfaces; 2016 Nov; 8(44):29977-29985. PubMed ID: 27797175
[TBL] [Abstract][Full Text] [Related]
7. Myristic Acid-Modified
Ying M; Wang S; Zhang M; Wang R; Zhu H; Ruan H; Ran D; Chai Z; Wang X; Lu W
ACS Appl Mater Interfaces; 2018 Jun; 10(23):19473-19482. PubMed ID: 29790744
[TBL] [Abstract][Full Text] [Related]
8. The functions and applications of A7R in anti-angiogenic therapy, imaging and drug delivery systems.
Lu L; Chen H; Hao D; Zhang X; Wang F
Asian J Pharm Sci; 2019 Nov; 14(6):595-608. PubMed ID: 32104486
[TBL] [Abstract][Full Text] [Related]
9. Dual-modified natural high density lipoprotein particles for systemic glioma-targeting drug delivery.
Cui L; Wang Y; Liang M; Chu X; Fu S; Gao C; Liu Q; Gong W; Yang M; Li Z; Yu L; Yang C; Su Z; Xie X; Yang Y; Gao C
Drug Deliv; 2018 Nov; 25(1):1865-1876. PubMed ID: 30474437
[TBL] [Abstract][Full Text] [Related]
10. Nanodisk-based glioma-targeted drug delivery enabled by a stable glycopeptide.
Wang H; Wang X; Xie C; Zhang M; Ruan H; Wang S; Jiang K; Wang F; Zhan C; Lu W; Wang H
J Control Release; 2018 Aug; 284():26-38. PubMed ID: 29885416
[TBL] [Abstract][Full Text] [Related]
11. Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma.
Zhang Y; Zhai M; Chen Z; Han X; Yu F; Li Z; Xie X; Han C; Yu L; Yang Y; Mei X
Drug Deliv; 2017 Nov; 24(1):1045-1055. PubMed ID: 28687044
[TBL] [Abstract][Full Text] [Related]
12. Transmembrane modification of tumor vascular targeting peptide A7R as molecular cargo delivery tool.
Zhang Q; Yang Z; Zhang J; Li Y; Dang X; Qu J; Pan X; Zhang J
Bioorg Chem; 2024 Apr; 145():107240. PubMed ID: 38412651
[TBL] [Abstract][Full Text] [Related]
13. EGFR/EGFRvIII Dual-Targeting Peptide-Mediated Drug Delivery for Enhanced Glioma Therapy.
Mao J; Ran D; Xie C; Shen Q; Wang S; Lu W
ACS Appl Mater Interfaces; 2017 Jul; 9(29):24462-24475. PubMed ID: 28685576
[TBL] [Abstract][Full Text] [Related]
14. Targeted Alpha Therapy of Glioma Using
Liu W; Ma H; Liang R; Chen X; Li H; Lan T; Yang J; Liao J; Qin Z; Yang Y; Liu N; Li F
Mol Pharm; 2022 Sep; 19(9):3206-3216. PubMed ID: 35993583
[TBL] [Abstract][Full Text] [Related]
15. DA7R: A 7-Letter Zip Code to Target PDAC.
Parrasia S; Rossa A; Roncaglia N; Mattarei A; Honisch C; Szabò I; Ruzza P; Biasutto L
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242749
[TBL] [Abstract][Full Text] [Related]
16. Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF(165) binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex.
Starzec A; Ladam P; Vassy R; Badache S; Bouchemal N; Navaza A; du Penhoat CH; Perret GY
Peptides; 2007 Dec; 28(12):2397-402. PubMed ID: 17983687
[TBL] [Abstract][Full Text] [Related]
17. A d-Peptide Ligand of Integrins for Simultaneously Targeting Angiogenic Blood Vasculature and Glioma Cells.
Ren Y; Zhan C; Gao J; Zhang M; Wei X; Ying M; Liu Z; Lu W
Mol Pharm; 2018 Feb; 15(2):592-601. PubMed ID: 29283582
[TBL] [Abstract][Full Text] [Related]
18. Multi-targeting Peptide-Functionalized Nanoparticles Recognized Vasculogenic Mimicry, Tumor Neovasculature, and Glioma Cells for Enhanced Anti-glioma Therapy.
Feng X; Yao J; Gao X; Jing Y; Kang T; Jiang D; Jiang T; Feng J; Zhu Q; Jiang X; Chen J
ACS Appl Mater Interfaces; 2015 Dec; 7(50):27885-99. PubMed ID: 26619329
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, Physicochemical and Biological Study of Gallium-68- and Lutetium-177-Labeled VEGF-A
Masłowska K; Witkowska E; Tymecka D; Halik PK; Misicka A; Gniazdowska E
Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35056995
[TBL] [Abstract][Full Text] [Related]
20. d-Retroenantiomer of Quorum-Sensing Peptide-Modified Polymeric Micelles for Brain Tumor-Targeted Drug Delivery.
Ran D; Mao J; Zhan C; Xie C; Ruan H; Ying M; Zhou J; Lu WL; Lu W
ACS Appl Mater Interfaces; 2017 Aug; 9(31):25672-25682. PubMed ID: 28548480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
